Literature DB >> 32103441

Instability in End-of-Life Care Preference Among Heart Failure Patients: Secondary Analysis of a Randomized Controlled Trial in Singapore.

Chetna Malhotra1,2, Meibo Hu3, Rahul Malhotra4,5, David Sim6, Fazlur Rehman Jaufeerally7, Filipinas G Bundoc3, Eric A Finkelstein3,4.   

Abstract

BACKGROUND: Efforts to improve quality of end-of-life (EOL) care are increasingly focused on eliciting patients' EOL preference through advance care planning (ACP). However, if patients' EOL preference changes over time and their ACP documents are not updated, these documents may no longer be valid at the time EOL decisions are made.
OBJECTIVES: To assess extent and correlates of changes in stated preference for aggressive EOL care over time.
DESIGN: Secondary analysis of data from a randomized controlled trial of a formal ACP program versus usual care in Singapore. PATIENTS: Two hundred eighty-two patients with heart failure (HF) and New York Heart Association Classification III and IV symptoms were recruited and interviewed every 4 months for up to 2 years to assess their preference for EOL care. Analytic sample included 200 patients interviewed at least twice.
RESULTS: Nearly two thirds (64%) of patients changed their preferred type of EOL care at least once. Proportion of patients changing their stated preference for type of EOL care increased with time and the change was not unidirectional. Patients who understood their prognosis correctly were less likely to change their preference from non-aggressive to aggressive EOL care (OR 0.66, p value 0.07) or to prefer aggressive EOL care (OR 0.53; p value 0.001). On the other hand, patient-surrogate discussion of care preference was associated with a higher likelihood of change in patient preference from aggressive to non-aggressive EOL care (OR 1.83; p value 0.03).
CONCLUSION: The study provides evidence of instability in HF patients' stated EOL care preference. This undermines the value of an ACP document recorded months before EOL decisions are made unless a strategy exists for easily updating this preference. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02299180.

Entities:  

Keywords:  advance care planning; decisional conflict; end-of-life care preference; heart failure; quality of life

Mesh:

Year:  2020        PMID: 32103441      PMCID: PMC7351942          DOI: 10.1007/s11606-020-05740-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  46 in total

1.  Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure.

Authors:  Daisy J A Janssen; Martijn A Spruit; Jos M G A Schols; Bianca Cox; Tim S Nawrot; J Randall Curtis; Emiel F M Wouters
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

2.  Are patients' preferences for information and participation in medical decision-making being met? Interview study with lung cancer patients.

Authors:  Koen Pardon; Reginald Deschepper; Robert Vander Stichele; Jan Bernheim; Freddy Mortier; Denis Schallier; Paul Germonpré; Daniella Galdermans; Willem Van Kerckhoven; Luc Deliens
Journal:  Palliat Med       Date:  2010-07-09       Impact factor: 4.762

Review 3.  Stability of end-of-life preferences: a systematic review of the evidence.

Authors:  Catherine L Auriemma; Christina A Nguyen; Rachel Bronheim; Saida Kent; Shrivatsa Nadiger; Dustin Pardo; Scott D Halpern
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

4.  Participation of Women in Clinical Trials: Not Yet Time to Rest on Our Laurels.

Authors:  Louise Pilote; Valeria Raparelli
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

5.  Determining Consistency of Surrogate Decisions and End-of-Life Care Received with Patient Goals-of-Care Preferences.

Authors:  Mi-Kyung Song; Sandra E Ward; Laura C Hanson; Maureen Metzger; SuHyun Kim
Journal:  J Palliat Med       Date:  2016-03-16       Impact factor: 2.947

6.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

7.  Impact of a Formal Advance Care Planning Program on End-of-Life Care for Patients With Heart Failure: Results From a Randomized Controlled Trial.

Authors:  Chetna Malhotra; David Sim; Fazlur Rehman Jaufeerally; Meibo Hu; Nivedita Nadkarni; Clarice Shu Hwa Ng; Genevieve Wong; Boon Cheng Tan; Jing Fen Lim; Claire Ya-Ting Chuang; Eric A Finkelstein
Journal:  J Card Fail       Date:  2020-01-25       Impact factor: 5.712

8.  Wishes regarding the use of life-sustaining treatments among elderly persons in Israel: an explanatory model.

Authors:  S Carmel; E Mutran
Journal:  Soc Sci Med       Date:  1997-12       Impact factor: 4.634

Review 9.  Long-term survival of cancer patients compared to heart failure and stroke: a systematic review.

Authors:  Vasileios Askoxylakis; Christian Thieke; Sven T Pleger; Patrick Most; Judith Tanner; Katja Lindel; Hugo A Katus; Jürgen Debus; Marc Bischof
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

Review 10.  Representation of the elderly, women, and minorities in heart failure clinical trials.

Authors:  Asefeh Heiat; Cary P Gross; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2002 Aug 12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.